Synthesis, Structure and Biological Evaluations of Zn(II) Pincer Complexes Based on S-Triazine Type Chelator

2,4- (3,5-dimethyl-1 -pyrazol-1-yl)-6-methoxy-1,3,5-triazine ( ) pincer ligand was used to synthesize the new [Zn(BPMT)(NCS) ] ( ) and [Zn(BPMT)(Br) ] ( ) complexes by a reaction with Zn(NO ) ·6H O in the presence of either KSCN or KBr, respectively. The structure of complex has been exclusively confirmed using single crystal X-ray diffraction. In this neutral heteroleptic complex, the is a pincer chelate coordinating the Zn(II) ion via three interactions with the two pyrazole moieties and the -triazine core. Hence, is a tridentate -chelate. The coordination environment of Zn(II) is completed by two strong interactions with two terminal SCN ions via the -atom. Hence, the Zn(II) is penta-coordinated with a distorted square pyramidal coordination geometry. Hirshfeld analysis indicated the predominance of H…H, H…C and N…H intermolecular interactions. Additionally, the S…H, S…C and S…N contacts are the most significant. The free ligand has no or weak antimicrobial, antioxidant and anticancer activities while the studied Zn(II) complexes showed interesting biological activity. Complex has excellent antibacterial activity against (2.4 μg/mL) and (4.8 μg/mL) compared to (4.8 μg/mL). Additionally, complex (78.09 ± 4.23 µg/mL) has better antioxidant activity than (365.60 ± 20.89 µg/mL). In addition, complex (43.86 ± 3.12 µg/mL) and (30.23 ± 1.26 µg/mL) have 8 and 12 times the anticancer activity of the free ligand (372.79 ± 13.64 µg/mL).